ProtoKinetix, Inc.

OTC:PKTX

Pharmaceutical Preparations·DALTON, OH

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

ProtoKinetix, Inc.

OTC:PKTX

Pharmaceutical Preparations·DALTON, OH

CEO

Smith Clarence Edward

CFO

Guzzetta Michael Richard

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$0

FY 2014

Adj. EBITDA

-$916,933

FY 2012

Net Income

-$415,479

FY 2024

EPS (Diluted)

-$0.01

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$377,350

FY 2021

Total Debt

$63,250

FY 2015

Net Cash

$314,100

FY 2015

Enterprise Value

—

Debt / EBITDA

0.3x

FY 2014

EV / EBITDA

—

Employees

—

CEO

Smith Clarence Edward

CFO

Guzzetta Michael Richard

Revenue

$0

FY 2014

Adj. EBITDA

-$916,933

FY 2012

Net Income

-$415,479

FY 2024

EPS (Diluted)

-$0.01

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$377,350

FY 2021

Total Debt

$63,250

FY 2015

Net Cash

$314,100

FY 2015

Enterprise Value

—

Debt / EBITDA

0.3x

FY 2014

EV / EBITDA

—

Employees

—